Seventy eight out of the 209 possible polychlorinated biphenyl (PCB) congeners
are chiral, nineteen of which exist under ambient conditions as stable rotational isomers
that are non-superimposable mirror images of each other. These congeners (C-PCBs)
represent up to 6% by weight of technical PCB mixtures and undergo considerable
atropisomeric enrichment in wildlife, laboratory animals and humans. The objective of this
review is to summarize our current knowledge of the processes involved in the absorption,
metabolism and excretion of C-PCBs and their metabolites in laboratory animals and humans.
C-PCBs are absorbed and excreted by passive diffusion, a process that, like other
physicochemical processes, is inherently not atropselective. In mammals, metabolism by
cytochrome P450 (P450) enzymes represents a major route of elimination for many C-PCBs.
In vitro studies demonstrate that C-PCBs with a
2,3,6-trichlorosubstituion pattern in one phenyl ring are readily oxidized to hydroxylated
PCB metabolites (HO-PCBs) by P450 enzymes, such as rat CYP2B1, human CYP2B6 and dog
CYP2B11. The oxidation of C-PCBs is atropselective, thus resulting in a species and
congener-dependent atropisomeric enrichment of C-PCBs and their metabolites. This
atropisomeric enrichment of C-PCBs and their metabolites likely plays a poorly understood
role in the atropselective toxicity of C-PCBs and, therefore, warrants further
investigation.